SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

12 Feb 2025 Evaluate
The Revenue for the quarter ended  December 2024 of Rs. 970.40 millions grew by 11.77 % from Rs. 868.20 millions.The Net Loss for the quarter ended December 2024 is Rs. -132.80 millions as compared to Net Loss of Rs. -181.80 millions of corresponding quarter ended December 2023The Operating Profit of the company witnessed a decrease to 149.50 millions from 162.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 970.40 868.20 11.77 2937.40 2160.90 35.93 3273.50 4025.50 -18.68
Other Income -80.10 131.10 -161.10 275.10 662.60 -58.48 630.50 521.60 20.88
PBIDT 149.50 162.80 -8.17 787.70 614.90 28.10 698.50 599.20 16.57
Interest 177.70 171.40 3.68 490.90 523.20 -6.17 681.90 579.20 17.73
PBDT -28.20 -8.60 227.91 296.80 61.20 384.97 -13.90 0.00 0.00
Depreciation 164.80 262.20 -37.15 491.00 754.90 -34.96 1016.10 962.00 5.62
PBT -193.00 -270.80 -28.73 -194.20 -693.70 -72.01 -1030.00 -962.00 7.07
TAX -60.20 -89.00 -32.36 -169.20 -240.80 -29.73 -265.90 -373.30 -28.77
Deferred Tax -60.20 -89.00 -32.36 -169.20 -240.80 -29.73 -376.50 -373.30 0.86
PAT -132.80 -181.80 -26.95 -25.00 -452.90 -94.48 -764.10 -588.70 29.79
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 15.41 18.75 -17.84 26.82 28.46 -5.76 21.34 14.89 43.35

Dishman Carbogen Amc Share Price

170.60 3.95 (2.37%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×